Executives from Merck Pharmaceuticals met with all the scientist and other professionals involved in getting to market a new drug product, from discovery to product launch.  The product is called sitagliptin and is known in the market by the trade names Januvia and Janumet, depending on the formulation and is used for the treatment of type II diabetes.